The period prevalence of double expression diffuse large B-cell lymphoma patients and its associated risk factors and treatment response in Hospital Universiti Sains Malaysia from 2004 to 2015
Background and Objective: Diffuse Large B-Cell Lymphoma (DLBCL) is a heterogeneous and complex disease. Its protein expression of MYC and BCL2 and/or BLC6 (Double Expression) is associated with poor response to standard treatment, thus poor prognosis. The aim is to determine the period prevalence o...
Saved in:
Main Author: | Yong, Teh Chee |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | http://eprints.usm.my/45621/1/Dr.%20Teh%20Chee%20Yong-24%20pages.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The immunohistochemical studies of double or triple protein lymphoma in diffuse large B-cell lymphoma and their correlation with clinicopathological parameters
by: Wahab, Wan Nor Najmiyah Wan Abdul
Published: (2017) -
Immunohistochemical expression of hedgehog proteins in diffuse large B-cell lymphoma
by: Azman, Siti Nur Lina
Published: (2016) -
Immunogenotypic characteristics of diffuse large B-cell lymphoma in Malaysia /
by: Phang, Kean Chang -
P16 tumour suppressor gene in diffuse large b-cell lymphoma /
by: Lee, Ee Soo
Published: (2009) -
Identification of epigenetic methylation silencing in diffuse large B cell lymphoma in East Coast Malaysia /
by: Lailatul Jalilah Mohd Ridah
Published: (2016)